# neumo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neumo-2

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.neumo.jp
- Latest round: Series A (Apr 23, 2026)
- Investors on record: 1

## About

Based in Japan, neumo Co., Ltd. specializes in enhancing auditory capabilities through brain science and technology, primarily addressing age-related hearing decline and its impact on cognitive health and social interactions.neumo Co., Ltd., founded in 2017 and headquartered in Tokyo, Japan, focuses on improving auditory functions through innovative sound training programs. The company has had one deal to date, with its most recent funding round occurring on April 23, 2026. The firm was founded by individuals dedicated to advancing auditory health, although specific names of the founders are not mentioned in available resources.neumo specializes in enhancing auditory capabilities through brain science and technology, primarily targeting age-related hearing decline, which affects social interactions and cognitive health. The company's core offerings include sound training programs and auditory perception services based on neurocognitive principles, aimed at improving listening skills and facilitating enjoyment in conversations and music among users. These services are designed for a diverse clientele, including older adults experiencing hearing loss, individuals seeking to maintain cognitive function, and organizations focused on wellness and healthcare initiatives. neumo's products serve markets in Japan and are tailored to meet the needs of both individual consumers and institutional clients, such as healthcare facilities and educational institutions.neumo generates revenue through a combination of direct-to-consumer services and partnerships with healthcare providers. The company's business model includes subscription-based access to their auditory training platforms and consultation services. Specific pricing plans for these services are structured to accommodate varying client needs, potentially offering tiered subscriptions for individuals and bulk licensing agreements for institutional clients. neumo's flagship offerings—such as their auditory training programs—are designed to provide measurable improvements in auditory perception, contributing to a sustainable revenue stream as clients seek ongoing support for hearing health and cognitive engagement.In April 2026, neumo raised an undisclosed amount in Series A funding from new investor D3 LLC. The company plans to utilize this funding to enhance the quality of life for individuals with hearing difficulties, alleviate the burden on their families and caregivers, and reduce long-term dementia risk. Future initiatives include the development of new auditory training products, with specific timelines for release not disclosed, and expansion into additional markets beyond Japan, though specific regions targeted for expansion have not been detailed.

## Funding rounds

- Series A, Apr 23, 2026 — D3 LLC

## Investors

- D3 LLC (https://capitalatlas.ai/funds/d3-llc) — Series A